AUSTIN, TX, Revisto, a pioneering AI-powered solution streamlining the medical, legal, and regulatory (MLR) review process for pharmaceutical marketing materials, announced it has secured $4 million in seed funding.
Revisto, a pioneering AI-powered solution streamlining the medical, legal, and regulatory (MLR) review process for pharmaceutical marketing materials, announced it has secured $4 million in seed funding. The round was led by LiveOak Ventures, with participation from Eli Lilly and Company, Tau Ventures, and Arkin Digital Health. This investment brings Revisto’s total funding to $6 million, positioning the company to transform the pharmaceutical and life science industry’s often tedious and financially burdensome approach to marketing compliance.
By VC News Daily
Source: VC News Daily